Glenmede Trust CO Na 10x Genomics, Inc. Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$36.95 - $82.41 $61,226 - $136,553	1,657 Added 32.81%	6,707 $303,000
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $2,673 - $6,997	48 Added 0.96%	5,050 $384,000
Q4 2021 Feb 15, 2022	SELL	$135.05 - $182.59 $405 - $547	-3 Reduced 0.06%	5,002 $745,000
Q3 2021 Nov 15, 2021	SELL	$145.58 - $192.14 $21,545 - $28,436	-148 Reduced 2.87%	5,005 $728,000
Q2 2021 Aug 16, 2021	BUY	$134.22 - $202.37 $691,635 - $1.04 Million	5,153 New	5,153 $1.01 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.42B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.